By Ben Butkus

Molecular diagnostics firm Seegene this week introduced a new technology called real amplicon detection PCR and said that it plans to develop a number of molecular diagnostic tests based on the method in coming months.

According to Seegene, real amplicon detection, or READ, PCR, combines the advantages of multiplex and nested real-time PCR, accelerates test processing by 400 percent, and increases specificity and sensitivity of pathogen detection 10- to 100-fold over current technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.